Sponsor Pipeline

Kyverna Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
6
Active Trials
2
Recruiting
1
Phase 3
5
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-25 NCT06588491
KYSA-8: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in…		 Trial completed
2026-07-25 NCT06588491
KYSA-8: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in…		 date change Completion moved earlier: 2026-12 -> 2026-06-25
Active Trials by Phase
Phase 2/3
1
Phase 2
1
Phase 1/2
3
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT06193889 KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With… Myasthenia Gravis Recruiting
Phase 2
NCT06384976 KYSA-7: A Study of Anti-CD19 CAR T-Cell Therapy, in Subjects With Refractory Primary and… Multiple Sclerosis, Primary Progressive Active, Not Recruiting
Phase 1/2
NCT06400303 KYSA-5: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in… Systemic Sclerosis Active, Not Recruiting
NCT05938725 KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in… Lupus Nephritis Active, Not Recruiting
NCT06342960 KYSA-3: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in… Lupus Nephritis Active, Not Recruiting
Not specified
NCT07403188 A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101 Refractory Lupus Nephritis Recruiting
Disease Areas
Lupus (SLE) (3) Multiple Sclerosis (2) Scleroderma (2) Myasthenia Gravis (1) Rheumatoid Arthritis (1)
Get alerts when Kyverna Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free